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Abstract
Background
Osteogenesis imperfecta (OI) is a heterogeneous hereditary connective tissue
disorder clinically hallmarked by increased susceptibility to bone fractures.
Methods
We analyzed a cohort of 77 diagnosed OI patients from 49 unrelated Pales-
tinian families. Next-generation sequencing technology was used to screen a
panel of known OI genes.
Results
In 41 probands, we identified 28 different disease-causing variants of 9 different
known OI genes. Eleven of the variants are novel. Ten of the 28 variants are
located in COL1A1, five in COL1A2, three in BMP1, three in FKBP10, two in
TMEM38B, two in P3H1, and one each in CRTAP, SERPINF1, and SERPINH1.
The absence of disease-causing variants in the remaining eight probands sug-
gests further genetic heterogeneity in OI. In general, most OI patients (90%)
harbor mainly variants in type I collagen resulting in an autosomal dominant
inheritance pattern. However, in our cohort almost 61% (25/41) were affected
with autosomal recessive OI. Moreover, we document a 21-kb genomic deletion
in the TMEM38B gene identified in 29% (12/41) of the tested probands, mak-
ing it the most frequent OI-causing variant in the Palestinian population.
Conclusion
This is the first genetic screening of an OI cohort from the Palestinian popula-
tion. Our data are important for genetic counseling of OI patients and families
in highly consanguineous populations.
Introduction
Osteogenesis imperfecta (OI) or brittle bone disease is a
rare heterogeneous hereditary disorder with an incidence
of 1:15,000 to 1:25,000 births (Stoll et al. 1989; Martin
and Shapiro 2007). The clinical hallmark of OI is a low
bone mass that causes bone fragility, easy fracturing, and
growth impairment. Other features may include blue scle-
rae, dentinogenesis imperfecta, and hearing loss (van Dijk
and Sillence 2014). The clinical heterogeneity of OI ranges
from hardly detectable mild OI with few fractures to peri-
natal lethality. Autosomal dominant (AD), autosomal
recessive (AR), and X-linked inheritance patterns have
been described previously. The current clinical
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classifications elaborating on the OI classification of 2010
reveal the importance of phenotyping for classifying and
diagnosing OI (Warman et al. 2011; van Dijk and Sillence
2014; Bonafe et al. 2015). Forlino and Marini (2016) sub-
divide OI genes in five functional groups according to the
pathway and mechanism in which they are involved. We
present our results according to these functional groups.
However, several reported OI genes cannot be classified,
including TAPT1, SEC24D, P4HB, SPARC, and MBTPS2
(OMIM#300294) (Garbes et al. 2015; Mendoza-Londono
et al. 2015; Rauch et al. 2015; Symoens et al. 2015;
Lindert et al. 2016).
Middle Eastern populations, especially Arabs, are highly
consanguineous because of cultural reasons. Population-
based surveys show consanguinity rates of 20–50% in all
marriages in Arab countries (Tadmouri et al. 2009). In
Palestine, this rate has been estimated to be about 40%
(Assaf and Khawaja 2009; Tadmouri et al. 2009; Sirdah
2014). Consequently, AR disorders are common in these
populations. In contrast to the high frequency of the AD
forms caused by defects in the structure or quantity of
type I collagen in nonconsanguineous populations (Byers
and Pyott 2012; Rohrbach and Giunta 2012), AR forms
of OI are expected to be more common in highly consan-
guineous populations. The many AR genes identified in
consanguineous families have revealed new pathogenic
mechanisms. Some genes have been subjected to intensive
study, such as CRTAP, P3H1, and PPIB, which encode
components of the collagen prolyl 3-hydroxylation
complex (Marini and Blissett 2013; Homan et al. 2014;
Forlino and Marini 2016) and BMP1, which encodes the
C-propeptidase of type I procollagen and causes AR OI
through a procollagen processing defect. In addition,
BMP1 activates lysl oxidase, which has a critical role in
collagen cross-linking (Panchenko et al. 1996; Borel et al.
2001). Other genes have not been fully explored: (i) SER-
PINF1, encoding the pigment epithelium-derived factor
protein (PEDF), which has a crucial role in bone home-
ostasis and osteoid mineralization (Minillo et al. 2014);
(ii) SP7, encoding the transcription factor Sp7 protein;
(iii) WNT1, encoding the proto-oncogene Wnt-1 protein;
and (iv) CREB3L1, encoding the endoplasmic reticulum
stress transducer “old astrocyte specifically induced sub-
stance” (OASIS) (Lapunzina et al. 2010; Keupp et al.
2013; Symoens et al. 2013). A recently identified AR OI
gene is TMEM38B, encoding the TRIC-B protein (Sha-
heen et al. 2012). It has been proposed that the TRIC-B
channel acts as a counter ion to facilitate the Ca2+ efflux
from the endoplasmic reticulum (ER) mediated by inosi-
tol 1,4,5-trisphosphate receptors (IP3Rs) (Fink and Veigel
1996). Impaired bone mineralization and insufficient col-
lagen matrix in bones have been reported in TRIC-B
knockout mice, which die immediately after birth from
respiratory complications. Moreover, it was proposed in
the same study that TRIC-B knockout osteoblasts inhibit
IP3R-mediated Ca2+ release, leading to impaired Ca2+ sig-
naling and Ca2+ store overload (Zhao et al. 2016). A
recent study based on data obtained from cells of OI
patients reported higher ER stress accompanied by defec-
tive matrix collagen due to the decreased synthesis, secre-
tion, and deposition of type I collagen, in addition to the
impaired assembly and lysyl hydroxylation of procollagen
fibers (Cabral et al. 2016). Here, we report for the first
time an in-depth molecular screening of a large cohort of
Palestinian OI families and describe a wide range of
mostly autosomal recessive variants, with phenotypes
ranging from mild to severe.
Materials and Methods
Ethical compliance
The study was approved by the ethics committee of
Ghent University Hospital (Belgium) and the ethics com-
mittee of Birzeit University (Palestine).
Patients
Forty-nine Palestinian families with 77 affected family
members participated in the study. Participating families
were distributed all over Palestine, with 38 residing in the
West Bank and 11 in Gaza. Thirty-two (65%) of the 49
families were consanguineous. Blood samples were
obtained from affected individuals after obtaining appro-
priate informed consent from the participant and/or the
legal guardians.
Cell culture and isolation of DNA and RNA
Genomic DNA was isolated and purified from whole
EDTA blood by Qiagen DNeasy Kit using standard proto-
cols (Qiagen, Frankfurt, Germany). Skin biopsies were
obtained from probands affected by a disease-causing
splice variant in FKBP10. RNA was isolated with the
RNeasy mini kit (Qiagen). Subsequently, cDNA was syn-
thesized using the M-MLV cDNA synthesis kit according
to the manufacturer’s instructions (Qiagen).
Analysis strategies
A total of 82 primer sets were developed to amplify the
exons and their intron boundaries of OI panel 1, associ-
ated with AD OI, including COL1A1 (OMIM# 120150),
COL1A2 (OMIM# 120160), and IFITM5 (OMIM#
614757); 185 primer sets were developed to amplify OI
panel 2, associated with AR OI, including SERPINF1
2 ª 2017 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Genetic Analysis of Osteogenesis Imperfecta O. Essawi et al.
(OMIM# 172860), SERPINH1 (OMIM# 600943), P3H1
(OMIM# 610339), FKBP10 (OMIM# 607063), TMEM38B
(OMIM# 611236), CRTAP (OMIM# 605497),
SP7 (OMIM# 606633), BMP1 (OMIM# 112264), CREB3L1
(OMIM# 616215), PLOD2 (OMIM# 601865), TAPT1
(OMIM# 612758), PPIB (OMIM# 123841),
SEC24D (OMIM# 607186), P4HB (OMIM# 176790), and
SPARC (OMIM# 182120). All primer sequences were
obtained from Pxlence (Dendermonde, Belgium). The
coding regions and flanking introns were amplified using a
2720 Thermal Cycler (Applied Biosystems, Inc., Foster city,
CA, USA). Depending on the clinical presentation and
family history, either OI panel 1 or OI panel 2 was ana-
lyzed. If the screening was negative, the other panel was
investigated. Samples (50 ng DNA) were prepared using
the Nextera sample preparation protocol (Nextera XT
DNA Sample Prep Kit) (Illumina, Inc., San Diego, CA,
USA) and sequenced on a MiSeq instrument (Illumina,
Inc.). Alterations were confirmed by bidirectional Sanger
sequencing using an ABI3730XL sequencer (Applied
Biosystems, Inc.). Nomenclature is based on the HGMD
guidelines and refers to NCBI reference sequence
NM_000088.3/NP_000079.2 for COL1A1, NM_000089.3/
NP_000080.2 for COL1A2, NM_006129.4/NP_006120.1
for BMP1, NM_006371.4/NP_006362.1 for CRTAP,
NM_022356.3/NP_071751.3 for P3H1, NM_018112.1/
NP_060582.1 for TMEM38B, NM_00
1207014.1/NP_001193943.1 for SERPINH1, NM_021939.3/
NP_068758.3 for FKBP10, and NM_002615.5/
NP_002606.3 for SERPINF1. Pathogenic variants were
evaluated with the Alamut software (Alamut Visual, Inter-
active Biosoftware, Rouen, France) and the Mutalyzer soft-
ware (https://mutalyzer.nl/batchNameChecker). The
results were submitted to the OI variant database (https://
oi.gene.le.ac.uk) (Dalgleish 1997, 1998).
To identify disease-causing variants, all alterations were
filtered against the OI variant database (https://oi.gene.
le.ac.uk), the dbSNP database (Sherry et al. 2001), and
the ExAc database (Lek et al. 2016) (MAF <1%). Variants
were considered pathogenic if they satisfied previously
published criteria (Symoens et al. 2012).
Linkage analysis
Microsatellite markers within the 1 Mb flanking the gene
being investigated were selected from the Genethon and
Marshfield genetic map for linkage analysis. Markers and
primer sequences are shown in Table S1. PCR reactions
were performed (reaction conditions are available upon
request). One lL PCR product was added to 10 lL of a
mixture of GeneScan 500 LIZ Size Standards (Applied
Biosystems, Inc.) and formamide, and analyzed on an
ABI3730XL Genetic Analyzer (Applied Biosystems, Inc.).
The results were analyzed using GeneMapper software V5.0
(Applied Biosystems, Inc.).
Results
Alterations causing defects in collagen
synthesis, structure, or processing
We identified variants in COL1A1, COL1A2, or BMP1 in
19 of the 49 Palestinian OI probands (Table 1). Eleven of
19 probands harbored 10 different COL1A1 disease-caus-
ing variants. Two probands had glycine substitutions in
the a-helical region c.3226G>A p.(Gly1076Ser) and
c.3118G>A p.(Gly1040Ser), and a third proband carried
an aspartate substitution in the C-propeptide domain
c.4237G>A p.(Asp1413Asn). The phenotype of these pro-
bands is in agreement with the reports that associate these
three substitutions with severe OI (Marini et al. 2007;
Bodian et al. 2009; Pyott et al. 2011; Barkova et al. 2015;
Lindahl et al. 2015). Three probands had a splice site
variant, including variants c.1200+1G>A and
c.1299+1G>A, previously reported to cause an in-frame
skip of exons 18 and 19, respectively, and a novel splice
site variant, c.3531+1G>T, predicted to cause an in-frame
skip of exon 47. Those three splice site variants were asso-
ciated with mild to moderate phenotypic features charac-
terized primarily by short stature and recurrent fractures,
which is in agreement with previous descriptions (Willing
et al. 1993; Benusiene and Kucinskas 2003). Finally, we
found four premature termination variants associated
with mild phenotypic features. The c.2426dup
p.(Ala811Cysfs*10) and c.3749del p.(Gly1250Alafs*81)
variants are novel, whereas the c.3567del p.(Gly1190-
Valfs*49) and c.189C>A p.(Cys63*) variants have been
reported previously (Dalgleish 1997, 1998; Lindahl et al.
2015).
Five probands had a COL1A2 variant. Four were gly-
cine substitutions located in the a-helical region of the a2
(I) chain. One of them, c.1991G>T p.(Gly664Val), was
novel, and segregation was confirmed in two affected
family members (Fig. 1, 5812). The fifth variant is an in-
frame deletion c.1031_1033del p.(Val345del) causing a
severe form of OI. Remarkably, only three probands har-
boring variants in one of the collagen genes have a posi-
tive family history of OI. Mosaicism is suspected in two
of those families because there were patients whose par-
ents did not exhibit any OI symptoms (Fig. 1, 5805 and
5806).
Three probands carried novel homozygous missense
variants in BMP1. The proband with the homozygous
variant c.688C>G p.(Arg230Gly) had a moderate to severe
phenotype and various deformities necessitating depen-
dency on a wheel chair. The second proband and his
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affected brother harbored a homozygous missense variant
c.691G>T p.(Asp231Tyr) and had a milder phenotype
with few fractures and mild deformities (Fig. 1, 5815).
The third proband with a homozygous missense variant,
c.818C>T p.(Ala273Val), had the most severe phenotype
with more than 100 fractures and severe mobility-limiting
deformities.
Alterations causing defects in collagen
modification
A novel homozygous nonsense variant, c.976C>T
p.(Gln326*), located in exon 5 of the CRTAP gene, was
identified in two probands residing in the same
geographical region. This variant resulted in a very severe
phenotype, including bone and pectus deformities, multi-
ple recurrent fractures, short stature, and congenital
hernia.
Two previously reported homozygous variants were
detected in the P3H1 gene, one nonsense variant,
c.2041C>T p.(Arg681*) (Pepin et al. 2013), and a splice
site variant, c.1080+1G>T (Fig. 1, 968 and 5819). Both
variants resulted in a severe OI phenotype, with extremely
short stature, short and deformed extremities, and signifi-
cant mobility impairment (Table 1). Moreover, a family
history of neonatal and childhood death was reported.
TMEM38B variants were identified in 12 probands and
9 affected family members (Fig. 1, 5820, 5821, 5826,
Figure 1. Pedigrees of the families that participated in this study and have more than one OI patient. All relevant family members are indicated.
Asterisk (*) indicates patients from whom DNA was obtained.
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5827, 5828, and 5831). A previously reported homozygous
exon 4 deletion (21 kb), g.32476_53457delinsATTAAGG-
TATA, p.(Gly152Alafs*5), was found in 11 probands.
One proband was compound heterozygous for this 21 kb
deletion and a nonsense variant, c.507G>A p.(Trp169*),
located in exon 4. This latter variant is generally associ-
ated with a severe early-onset form of OI characterized by
bowing of the limbs and multiple fractures, mostly of the
femur. In addition, some individuals have blue sclerae,
bone deformities, and/or dentinogenesis imperfecta, but
none have hearing loss (Table 1). We identified a shared
haplotype between the 12 probands, indicating that the
deletion most likely represents a founder alteration
(Fig. 2).
Alterations causing defects in collagen
folding and cross-linking
A novel homozygous small genomic deletion was identified
in exon 3 of the SERPINH1 gene, c.314_325del p.(Glu105_-
His108del). This in-frame deletion caused the loss of four
amino acid residues and resulted in a moderate to severe
phenotype in an 18 months old proband presenting with
blue sclerae, joint hypermobility, pectus deformity,
osteopenia, and multiple recurrent fractures, in addition to
general growth and developmental delay (Table 1).
Three different homozygous variants in the FKBP10
gene were identified in four probands. The previously
described nonsense variant c.1330C>T p.(Gln444*) segre-
gated in four patients of the same family (Fig. 1, 5835). A
novel splice site variant, c.391+4A>T, was identified in
two probands originating from the same city, which indi-
cates that the families could be related. The pedigree of
the family containing eight patients harboring the splice
site variant is presented in Figure 1_5833. mRNA studies
revealed an out-of-frame skip of exon 2 of the FKBP10
gene (data not shown). A third proband had a novel
homozygous frameshift variant, c.1276del
p.(Gln426Argfs*10) (Fig. 1, 5836). All affected individuals
were diagnosed with Bruck syndrome based on recurrence
of long bone fractures and congenital contractures typical
of Bruck syndrome. In addition, scoliosis and/or pectus
deformities (Table 1) occurred in accordance with previ-
ously published data (Alanay et al. 2010; Shaheen et al.
2011; Schwarze et al. 2013).
Alterations causing defects in bone
mineralization
In a proband aged 7 years, we identified a homozygous
missense variant, c.242C>G p.(Ser81Cys), in exon 3 of
the SERPINF1 gene. The patient had recurrent and multi-
ple fractures, but with normal sclerae and teeth (Table 1).
The proband responded poorly to bisphosphonate treat-
ment, as reported for patients with SERPINF1-related OI
(Homan et al. 2011; Venturi et al. 2012; Minillo et al.
2014).
Discussion
We performed mutation analysis on a cohort of 49 Pales-
tinian OI families. By using an OI gene panel NGS
screening strategy, we identified variants of known OI
genes in 41 probands, corresponding to a variant uptake
rate of 84%. In contrast to the OI populations studied so
far, more than half of the Palestinian OI probands (25/
41) have a recessive form of OI due to high rates of con-
sanguinity. Consanguinity was more prevalent in our
study population than in the general Palestinian popula-
tion (65% vs. 39%), indicating ascertainment bias in fam-
ilies with possible recessive genetic disorders (Table 1).
Eight probands, of whom six belong to consanguineous
families, did not have any disease-causing variant in the
known OI genes, reflecting further genetic heterogeneity
in OI.
In total, we identified 28 different variants in nine OI
genes, including 10 COL1A1, five COL1A2, three BMP1,
three FKBP10, two TMEM38B, two P3H1, one CRTAP,
one SERPINF1, and one SERPINH1 (Table 1).
The phenotypes of patients with COL1A1 and COL1A2
variants (Table 1) were in line with previously reported
genotype–phenotype correlations, with haploinsufficiency
Figure 2. Haplotype analysis for the 12 probands with in an intragenic TMEM38B marker and five flanking markers. The green box indicates the
intragenic marker D9S2107.
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resulting in milder phenotypic abnormalities and patho-
genic missense variants causing more severe phenotypes
(Gentile et al. 2012; Vandersteen et al. 2014). However,
the novel splice site variant c.3531+1G>T is associated
with moderate phenotypic features, which is at odds with
an earlier report that this variant resulted in mild OI
(Willing et al. 1994).
We identified three novel homozygous BMP1 missense
variants affecting highly conserved amino acids located in
the catalytic metalloprotease domain, which may thus
interfere with the enzymatic activity of the BMP1/tolloid-
like protein. Hitherto, four BMP1 missense variants have
been reported (Asharani et al. 2012; Martinez-Glez et al.
2012; Valencia et al. 2014; Cho et al. 2015; Syx et al.
2015). Two of them, c.747C>G p.(Phe249Leu) and
c.808A>G p.(Met270Val), are in the same domain as the
variants we identified (Fig. S1) and it diminishes BMP1/
mTLD proteolytic activity, resulting in impaired secretion
of the protein (Martinez-Glez et al. 2012; Cho et al.
2015). The phenotypes of those two patients were severe
in accordance with the phenotype of our patient harbor-
ing the c.818C>T p.(Ala273Val) variant. Nevertheless, the
other two patients harboring the c.688C>G p.(Arg230Gly)
and c.691G>T p.(Asp231Tyr) variants have a moderate
and a mild phenotype, respectively (Table 1). Highly vari-
able phenotypes associated with BMP1 variants have been
recently reported (Pollitt et al. 2016), but further investi-
gation of the correlating molecular pathogenesis is
needed. In agreement with previous observations (Bal-
dridge et al. 2008), both variants of CRTAP and P3H1
caused severe OI (Table 1). Notably, the P3H1 splice site
variant c.1080+1G>T has been previously described as the
“West African allele’’ (Cabral et al. 2007; Pepin et al.
2013), but it seems to be more widely spread.
Remarkably, we found a recurrent exon 4 deletion
p.(Gly152Alafs*5) in TMEM38B in 12 probands, making
it the most frequent variant among the Palestinian OI
patients. This variant has been reported previously in
three Saudi Arabian families (Shaheen et al. 2012) and in
three Israeli Arab Bedouin families (Volodarsky et al.
2013). The latter families have the same ancestry as the
Palestinian population. Haplotype analysis suggests a
founder effect for this particular variant. The genotype–
phenotype correlation is in line with the previous reports,
so we recommend evaluation of this variant in Palestinian
families with moderate AR OI (Table 1).
The SERPINH1 variant reported here is the first in-
frame genomic SERPINH1 deletion to be identified,
though its phenotype of moderately severe OI does not
differ from the phenotype caused by variants generated
by a premature termination codon (PTC) (Christiansen
et al. 2010; Duran et al. 2015). Consistent with previous
observations (Schwarze et al. 2013), patients with variants
in the FKBP10 gene were diagnosed with Bruck syndrome
because of congenital contractures. Notably, OI severity
varied widely (Table 1).
The proband harboring a SERPINF1 missense variant
has a milder phenotype than the patients previously
reported (Becker et al. 2011; Homan et al. 2011; Capar-
ros-Martin et al. 2013; Cho et al. 2013; Minillo et al.
2014; Stephen et al. 2015), possibly because the mutant
PEDF protein retains some activity. Although the
c.242C>G p.(Ser81Cys) missense variant has been
reported as a variant with uncertain clinical significance
in the Clinvar database (Variation ID 218613) and with
an allele frequency in ExAC of about 0.1%, the amino
acid is well conserved and is located directly next to a
putative receptor binding site of the PEDF protein
(Fig. S2). Missense variants in SERPINF1 were
found to underlie otosclerosis in three families (Ziff et al.
2016), but our patient aged 7 years had no hearing
impairment.
In conclusion, AR forms of OI are the most prevalent
(>60%) in the Palestinian OI population. This finding
emphasizes the importance of genetic analysis of AR OI
genes in Palestinians with OI in order to reduce the risk
of this devastating disorder. A TMEMB38B deletion was
found to be the most common variant among the Pales-
tinian OI patients. In eight probands we did not identify
any disease-causing variant in the known OI genes, mak-
ing them suitable for exome sequencing in order to iden-
tify the underlying genetic defects. Such analysis will
probably lead to the identification of new OI genes.
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